This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q16.1 (congenital atresia/stenosis of the external auditory canal) | Special Copayment Reduction: V291 (rare disease) |
| B. Synonyms | Congenital absence, atresia, and stricture of the (external) auditory canal |
| C. Adult onset | Likelihood of first presentation in adulthood very low — external auditory canal atresia/stenosis is a congenital structural malformation mostly found at birth or on physical examination in infancy. In mild unilateral stenosis, diagnosis is rarely made when the patient first visits an otolaryngologist in childhood or adulthood for recurrent otitis externa or otorrhea, but this represents belated recognition of a pre-existing anatomical abnormality rather than the onset of new pathology. |
| 1. History | First described in 19th-century European otolaryngology. Temporal bone CT (1970s) and the introduction of the Jahrsdoerfer score systematized surgical indications and prognostic prediction. The introduction of implantable bone conduction hearing devices (BAHA) improved auditory rehabilitation. |
| 2. Causes | Failure of recanalization of the external auditory canal epithelial plug at 4–10 weeks of gestation. Multiple causes including genetic syndromes (Treacher Collins, CHARGE), rubella, drug exposure, and multifactorial inheritance. |
| 3. Genetics | Mostly multifactorial inheritance. When syndromic, causative genes such as TCOF1 and CHD7 are involved. Chromosomal variants such as 22q11.2 deletion and CMA abnormalities are possible. Genetic counseling recommended. |
| 4. General epidemiology | About 1 in 10,000–20,000 births. Unilateral 2–3 times as common as bilateral. Associated with microtia in about 60–90%. Slightly more common in males. |
| 5. Pathophysiology | Failure of recanalization (atresia) or incomplete recanalization (stenosis) during formation of the external auditory canal derived from the first branchial cleft. Impaired neural crest cell migration. Associated with abnormal craniofacial development due to syndrome-related genes. |
| 6. Symptoms | Conductive hearing loss (40–70 dB), recurrent otitis externa (stenosis), otorrhea, cerumen accumulation, otalgia. Risk of language development disorders in bilateral atresia. |
| 7. Signs | Absence or narrowing of the external auditory canal and an atresia plate on otoscopy. Conductive hearing loss on pure-tone audiometry and ABR. Evaluation of the atresia plate and middle ear development on temporal bone HRCT. |
| 8. Screening | Newborn hearing screening (AOAE/AABR); identification of external ear abnormalities on newborn physical examination. Otoscopy and HRCT in children with symptoms (recurrent otitis externa). |
| 9. Diagnosis | Hearing tests (PTA, ABR, ASSR), temporal bone HRCT, Jahrsdoerfer grading, genetic testing (when syndromic). Evaluation of the facial nerve course is essential. |
| 10. Treatment | Bilateral atresia: auditory rehabilitation with early bone conduction hearing aids or BAHA. Surgical canaloplasty is recommended with a Jahrsdoerfer score of 5 or more, after age 5–10. With associated microtia, hearing surgery after auricular reconstruction. Unilateral: observation or surgery as an option. |
| 11. Prognosis | Hearing improves after canaloplasty (conductive loss reduced by 20–30 dB). Restenosis about 15–30%. If inner ear function is normal, recovery of speech perception is expected. Quality-of-life studies on the choice of surgery for unilateral cases are ongoing. |
| 12. Prevention | Rubella vaccination before pregnancy, avoidance of risky drugs, diabetes control. Early diagnosis through newborn hearing screening. Prevention of cholesteatoma by regular cerumen removal in patients with stenosis. |
| 13. References | Jahrsdoerfer RA et al. Ann Otol Rhinol Laryngol 1992; Declau F et al. Laryngoscope 2001 and 8 others |
The first systematic clinical descriptions of congenital atresia/stenosis of the external auditory canal emerged with the development of European otolaryngology in the early 19th century. In 1845, the Polish physician Antoni Lemak described the clinical findings of external auditory canal atresia and stenosis, and in the late 19th century German otolaryngologists systematically classified congenital external ear malformations. In 1883, Adam Politzer clinically explained the association between external auditory canal abnormalities and abnormal middle ear development.
In the early 20th century, surgical correction of external and middle ear malformations began to be attempted. With advances in otolaryngological surgical techniques in the 1920s–30s, canaloplasty was performed for congenital aural atresia. However, the results of early surgery were poor, and understanding of inner ear function evaluation and middle ear reconstruction was lacking. With the dramatic progress of otology in the 1960s–70s, particularly the introduction of temporal bone microsurgery, the results of external auditory canal and middle ear reconstruction improved greatly.
The introduction of CT (1970s) revolutionized the evaluation of congenital external ear malformations. High-resolution temporal bone CT (HRCT) made it possible to accurately evaluate before surgery the anatomy of the external auditory canal, the development of the middle ear and mastoid, ossicular abnormalities, and abnormalities in the course of the facial nerve. In 1992, the atresia grading system proposed by Meredith Kunkel and William Cronin was used as a standard for surgical indications and prognostic prediction. The 1999 Yanagisawa classification and the Jahrsdoerfer scoring system, currently the most widely used, are used to predict surgical outcomes. Currently, bone-anchored hearing aids (BAHA), implantable middle ear hearing devices, and cochlear implants (with associated inner ear malformations) are used for auditory rehabilitation, and a multidisciplinary approach integrating microtia reconstruction and auditory rehabilitation has become the standard for combined microtia and aural atresia malformations.
In Korea, with advances in otolaryngology, plastic surgery, and auditory rehabilitation since the 1980s–90s, surgical and audiological management of patients with congenital external auditory canal atresia/stenosis has improved. Patients registered under rare disease Special Copayment Reduction V291 receive copayment reduction benefits, and specialized management is provided at multidisciplinary otolaryngology clinics.
Congenital atresia/stenosis of the external auditory canal (Q16.1) is a congenital malformation caused by a defect in the embryonic formation of the external auditory canal (EAC). The external auditory canal develops at 4–10 weeks of gestation from the first pharyngeal pouch and the first branchial cleft. Abnormalities in this developmental process cause external auditory canal atresia or stenosis.
The causes of congenital external auditory canal atresia/stenosis are broadly divided into genetic and environmental factors. As genetic factors, familial cases following an autosomal dominant inheritance pattern have been reported, though sporadic occurrence is more common. It may also occur together with chromosomal abnormalities (trisomy 21, 18, 13, Turner syndrome, 22q11.2 deletion syndrome). In multiple malformation syndromes—Treacher Collins syndrome (TCOF1 variants), Goldenhar syndrome, CHARGE syndrome (CHD7 variants), Nager syndrome—external auditory canal atresia/stenosis appears as a major component.
Environmental factors: rubella infection in early pregnancy (4–12 weeks of gestation) can cause external ear malformations as part of TORCH syndrome. Exposure to certain drugs in early pregnancy, such as thalidomide, retinoids, and meclizine, is associated with abnormal external ear development. Diabetes and alcohol exposure in early pregnancy are also reported as risk factors. Most congenital external auditory canal atresia/stenosis is known to follow a multifactorial inheritance pattern and is understood to arise from the interaction of multiple factors rather than a specific single cause.
Congenital atresia/stenosis of the external auditory canal is divided into isolated occurrence and syndromic occurrence. Most isolated cases follow a multifactorial inheritance pattern, and established specific single-gene defects are rare. In syndromic cases, the causative gene of the syndrome is involved.
Treacher Collins syndrome (MIM 154500): autosomal dominant inheritance. Caused by variants in the TCOF1 (treacle ribosome biogenesis factor 1), POLR1D, and POLR1C genes. TCOF1 is involved in rDNA transcription in the nucleolus and plays a key role in neural crest cell development. In this syndrome, external auditory canal atresia/stenosis, microtia, facial hypoplasia, and bilateral conductive hearing loss occur.
CHARGE syndrome (MIM 214800): occurs mainly from de novo variants in the CHD7 (chromodomain helicase DNA binding protein 7) gene. An acronym for Coloboma, Heart defect, Atresia of choanae, Retardation of growth, Genital abnormalities, Ear abnormalities; external ear malformations including external auditory canal atresia/stenosis are a major component.
Goldenhar syndrome (Oculoauriculovertebral spectrum): mostly sporadic, with heterogeneous genetic causes. Characterized by unilateral facial hypoplasia, external ear malformations (microtia, external auditory canal atresia), epibulbar dermoid, and cervical spine abnormalities.
In isolated external auditory canal atresia/stenosis, 22q11.2 microdeletions and copy number variants (CNV) are found in some patients. During genetic counseling, chromosomal microarray (CMA) and whole-exome sequencing (WES) are recommended to search for causative genes. When there is a family history, hearing evaluation and otolaryngological examination of family members are recommended.
The incidence of congenital aural atresia is reported to be about 1 in 10,000–20,000 births. External auditory canal stenosis is slightly more common than atresia, and because mild stenosis may be overlooked, the actual prevalence may be higher. Unilateral cases are about 2–3 times more common than bilateral, with a tendency to occur slightly more on the right side. There are reports that it occurs about twice as often in males, but some studies are inconsistent.
Co-occurrence with microtia is common; external auditory canal atresia/stenosis accompanies about 60–90% of patients with microtia. Conversely, microtia accompanies about 70–85% of patients with external auditory canal atresia. Middle ear malformations (ossicular malformations, tympanic membrane abnormalities) also frequently appear together with external auditory canal atresia.
Epidemiology in Korea: systematic epidemiological data on congenital external ear malformations in Korea are limited, but the incidence is estimated to be similar to worldwide rates. It is eligible for rare disease Special Copayment Reduction V291 registration, and copayment reduction benefits apply upon registration. Some cases are found as unilateral or bilateral conductive hearing loss in newborn hearing screening for congenital hearing loss (the newborn hearing screening program), and consultation with an otolaryngologist is recommended. In bilateral atresia, early auditory rehabilitation is essential.
Slightly higher incidences of microtia and external auditory canal atresia are reported in Hispanic and Asian populations, but they occur in all ethnic groups worldwide. Genetic and developmental factors, rather than socioeconomic factors, are the main determinants. Associated inner ear malformations (cochlear dysplasia, semicircular canal dysplasia) carry a worse prognosis than isolated external auditory canal atresia, so inner ear evaluation is essential.
The pathogenesis of congenital atresia/stenosis of the external auditory canal is explained by abnormalities in the embryonic formation of the external auditory canal. In normal development, the external auditory canal forms over 4–10 weeks of gestation by medial invagination from the first branchial cleft of ectodermal origin. In this process, an epithelial plug of the external auditory canal first forms and is then reopened (recanalization) to form the lumen. Failure of recanalization results in atresia, and incomplete recanalization results in stenosis.
External auditory canal development is closely linked to middle ear development. The first pharyngeal pouch is the origin of the middle ear cavity, eustachian tube, and mastoid air cells, and abnormal development of these structures explains the middle ear malformations that appear with external auditory canal atresia. The ossicles (malleus, incus, stapes) derive from the mesoderm of the first and second branchial arches, and neural crest cells contribute to the formation of these structures. Impaired neural crest cell migration is understood as the key mechanism of combined external and middle ear malformations.
In syndrome-related external auditory canal atresia, the causative gene of the syndrome affects neural crest cell differentiation and migration. In Treacher Collins syndrome due to TCOF1 variants, the known pathophysiology is increased p53-mediated apoptosis of neural crest cells, leading to a shortage of mesodermal cells needed to form facial and external ear structures. In CHARGE syndrome due to CHD7 variants, impaired chromatin remodeling causes abnormal development of multiple organs.
The mechanism of external auditory canal stenosis is incomplete recanalization, so the canal diameter forms smaller than normal (about 4–7 mm). A stenotic external auditory canal carries a high risk of otorrhea (otalgia) and retained discharge (cerumen impaction and epithelial debris accumulation), and is a risk factor for recurrent otitis externa and cholesteatoma formation. In external auditory canal stenosis with a diameter of less than 4 mm, surgical correction is considered.
The clinical symptoms of congenital atresia/stenosis of the external auditory canal vary with the degree of atresia/stenosis, whether it is unilateral or bilateral, and whether there are associated middle and inner ear malformations.
Hearing loss (conductive hearing loss): the most important functional symptom. When the external auditory canal is closed, sound waves are not transmitted via the tympanic membrane–ossicular pathway (air conduction), causing conductive hearing loss. Depending on the degree of atresia, a conductive hearing loss of about 40–70 dB occurs. In unilateral atresia, if hearing in the opposite ear is normal, language development is not greatly affected, but difficulty in noisy environments, impaired sound localization, and vulnerability in listening environments such as classrooms and lecture halls become problems. In bilateral atresia, severe language development disorders occur without hearing rehabilitation.
Symptoms in external auditory canal stenosis: the main symptoms of external auditory canal stenosis are otorrhea, aural fullness, otalgia, and recurrent otitis externa. Keratin debris and cerumen accumulate in the stenotic canal, increasing the risk of 'cholesteatoma' formation. Cholesteatoma can cause inflammation and bone destruction, leading to middle ear complications.
Symptoms due to associated malformations: with associated microtia, the abnormal appearance of the external ear is the main external finding. With associated ossicular malformations of the middle ear, conductive hearing loss is more severe. With associated CHARGE syndrome or Treacher Collins syndrome, combined symptoms due to multiple organ malformations appear. When an abnormal facial nerve course is present (associated with external auditory canal atresia), the risk of facial nerve injury during surgery increases, so the nerve course is evaluated by CT before surgery.
The physical signs of congenital external auditory canal atresia/stenosis are evaluated by otoscopic examination, hearing tests, and temporal bone imaging.
Otoscopic findings: in external auditory canal atresia, the canal lumen is not visible on otoscopy, and a bony or fibrous atretic plate is observed at the canal opening or within the canal. In external auditory canal stenosis, insertion of the otoscope is difficult or impossible, and accumulation of keratin debris and cerumen inside the stenosis is observed. The tympanic membrane is absent or malformed depending on the form of atresia; in stenosis, the tympanic membrane may be visible but is abnormal.
Hearing test findings: pure-tone audiometry (PTA) shows air-conduction hearing loss (40–70 dB) and an air-bone gap. Bone-conduction hearing (reflecting inner ear function) is normal if there is no inner ear abnormality. Auditory brainstem response (ABR) is the standard for hearing evaluation in newborns and infants, and the conductive loss is quantified from the difference between bone-conduction ABR and air-conduction ABR. Otoacoustic emissions (OAE) cannot be measured when the external auditory canal is closed.
Temporal bone CT findings: high-resolution temporal bone CT (HRCT) is key to diagnosis and surgical planning. The form of the atretic plate (bony, fibrous, mixed), its thickness, and the development of the middle ear (middle ear cavity size, ossicular malformations, abnormal facial nerve course, position of the internal auditory canal) are evaluated. Surgical indications and prognosis are predicted using the Jahrsdoerfer scoring system (out of 10 points): items such as presence of the stapes (2 points), ossicular mobility, middle ear cavity size, facial nerve course, mastoid pneumatization, auricle, and external auditory canal are scored, and surgery is considered with 5 points or more.
The main screening for congenital external auditory canal atresia/stenosis consists of neonatal hearing screening and identification of external ear abnormalities on newborn physical examination.
Newborn hearing screening: newborn hearing screening using automated otoacoustic emissions (AOAE) or automated auditory brainstem response (AABR) is effective in detecting air-conduction hearing abnormalities in bilateral external auditory canal atresia. In unilateral atresia, screening may be missed because the opposite normal ear passes the test, so an external ear physical examination is performed concurrently. In Korea, newborn hearing screening is mandated by law (the Mother and Child Health Act) and performed at delivery facilities nationwide.
Newborn external ear physical examination: on newborn physical examination, the external ear morphology (auricle size, shape, auricle position) and the presence of the external auditory canal opening are checked. If microtia, auricular malformation, or absence of the canal opening is found, a specialist otolaryngology examination and temporal bone CT are performed.
Screening for external auditory canal stenosis: mild external auditory canal stenosis may be missed in neonatal screening. At routine pediatric checkups, the size of the canal opening is checked by otoscopy, and the possibility of stenosis is evaluated when recurrent otitis externa, otorrhea, or cerumen accumulation is frequent.
Evaluation for associated syndromes: when microtia or external auditory canal atresia is found, multi-organ malformation evaluation and genetic testing are performed to assess for associated syndromes such as Treacher Collins, CHARGE, and Goldenhar syndrome.
The diagnosis of congenital external auditory canal atresia/stenosis is made by a combination of physical examination, hearing tests, and temporal bone imaging.
Hearing tests: depending on age, behavioral audiometry, visual reinforcement audiometry (VRA), play audiometry, and pure-tone audiometry (PTA) are performed. ABR (auditory brainstem response) is the standard for objective hearing evaluation in newborns, infants, and patients who have difficulty cooperating. The conductive loss is quantified by the air-bone gap. To evaluate inner ear function, bone-conduction ABR or bone-conduction ASSR (auditory steady-state response) is performed.
High-resolution temporal bone CT (HRCT): an essential preoperative test that evaluates the form and thickness of the atretic plate, the development of the middle ear (middle ear cavity volume, type of ossicular malformation, facial nerve course, cochlear and semicircular canal development), and the position of the carotid canal and jugular bulb. The Jahrsdoerfer score is calculated to predict surgical indications and the likelihood of expected hearing improvement.
Specialist otolaryngology examination: otoscopy evaluates the condition of the external auditory canal, the location and form of the atretic plate, and whether the middle ear is visible. With associated microtia, a plan for auricular reconstruction is established using auricular morphology classification (Marx classification or Nagata classification).
Genetic testing: when a syndrome is suspected, chromosomal microarray (CMA), whole-exome sequencing (WES), or syndrome-related gene panel testing is performed. Cause identification and family counseling are carried out in collaboration with genetic counselors.
Treatment of congenital external auditory canal atresia/stenosis is divided into hearing rehabilitation and surgical reconstruction of the external auditory canal. Treatment decisions are made by comprehensively considering unilateral/bilateral involvement, the Jahrsdoerfer score, age, and associated microtia.
Nonsurgical auditory rehabilitation: newborns with bilateral external auditory canal atresia begin auditory input by wearing a bone conduction hearing aid (BCHA) within the first month of life. Because a bone conduction hearing aid transmits vibrations to the cochlea through bone, it can be used without an external auditory canal. In children, according to age criteria, an implantable bone conduction hearing device (BAHA: bone-anchored hearing aid, e.g., Cochlear Baha, Oticon Ponto) is implanted after age 5. BAHA involves inserting a titanium fixture into the skull and connecting an external processor, and its wearing comfort and sound quality are superior to those of non-implantable bone conduction hearing aids.
Surgical canaloplasty: surgery aimed at hearing improvement is considered with a Jahrsdoerfer score of 5 or more (especially 7 or more). The recommended timing of surgery is after auricular reconstruction for associated microtia (usually after age 6–10). Surgery is performed after identifying the location of the atretic plate, the approach to the middle ear cavity, and the facial nerve course through 3D planning based on temporal bone CT. Intraoperative facial nerve monitoring is essential and is key to preventing nerve injury. After surgery, ear canal stents, silicone tubes, and regular canal dilation procedures are needed to prevent restenosis of the external auditory canal (about 15–30%).
Management of unilateral external auditory canal atresia: whether to operate is decided by comprehensively considering the preferences of the patient and caregivers, the Jahrsdoerfer score, and surgical risks (facial nerve injury, etc.). Conservative options (BAHA use or follow-up without treatment) are also valid choices. Quality-of-life studies have reported that BAHA use in unilateral atresia improves sound localization and listening ability in noisy environments.
Management of cholesteatoma: when cholesteatoma has formed in a stenotic external auditory canal, canal wall down mastoidectomy to remove it completely or conservative surgery is required. Regular follow-up is important given the possibility of cholesteatoma recurrence.
Hearing improvement after canaloplasty is closely related to the Jahrsdoerfer score. In patients with 7–10 points, the proportion whose postoperative air-bone gap improves to 30 dB or less is reported to be about 60–70%. With lower scores (5–6 points), the improvement rate is lower and the risk of facial nerve injury is relatively higher. Restenosis occurs in about 15–30% on long-term follow-up, requiring ongoing canal dilation management. Facial nerve injury is reported in about 1–3% and is the most serious complication of surgery.
Even patients with unilateral external auditory canal atresia followed without surgery maintain considerable listening function with the opposite ear if inner ear function is normal. With BAHA use, sound localization and listening ability in noisy environments improve. When inner ear malformations are present (cochlear dysplasia, semicircular canal dysplasia), bone-conduction hearing is also impaired, so postoperative hearing improvement is limited, and a cochlear implant may be considered. Because language development and academic achievement depend greatly on the timing and quality of auditory rehabilitation, early initiation of auditory rehabilitation in bilateral atresia is key to improving prognosis. In terms of quality of life, patients who receive appropriate auditory rehabilitation show relatively good outcomes in education, employment, and social participation.
No specific primary prevention method for congenital external auditory canal atresia/stenosis has been established. However, indirect prevention by avoiding known risk factors is possible.
Primary prevention — avoiding risk factors: to prevent rubella infection in early pregnancy (4–12 weeks), checking rubella antibodies and vaccination before pregnancy are recommended. The MMR vaccine is given before pregnancy, and vaccination is avoided during pregnancy. Exposure to teratogenic drugs (retinoids, thalidomide, some antiepileptic drugs) in early pregnancy is minimized, and if these drugs are needed, a specialist is consulted before pregnancy. Alcohol intake during pregnancy is prohibited. Diabetes control before pregnancy reduces the overall risk of congenital malformations.
Secondary prevention — early diagnosis and auditory rehabilitation: external auditory canal atresia/stenosis is detected early through newborn hearing screening and physical examination, and immediate auditory rehabilitation (bone conduction hearing aids, BAHA, etc.) is provided to minimize effects on language and cognitive development. In bilateral atresia, starting auditory rehabilitation within the first month of life is recommended.
Tertiary prevention — preventing complications: in patients with external auditory canal stenosis before and after surgery, cholesteatoma formation is prevented by regular removal of cerumen and keratin. To prevent postoperative restenosis, ear canal stents, regular canal dilation, and regular otolaryngology follow-up are needed. Facial nerve function is assessed before and after surgery for early detection of complications.